These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12792668)

  • 1. Participation of adenosine receptors in neuroprotection.
    Ribeiro JA; Sebastiao AM; de Mendonca A
    Drug News Perspect; 2003 Mar; 16(2):80-6. PubMed ID: 12792668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine receptors in the nervous system: pathophysiological implications.
    Ribeiro JA; Sebastião AM; de Mendonça A
    Prog Neurobiol; 2002 Dec; 68(6):377-92. PubMed ID: 12576292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders.
    Abbracchio MP; Ceruti S; Brambilla R; Franceschi C; Malorni W; Jacobson KA; von Lubitz DK; Cattabeni F
    Ann N Y Acad Sci; 1997 Oct; 825():11-22. PubMed ID: 9369971
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenosine receptors and the central nervous system.
    Sebastião AM; Ribeiro JA
    Handb Exp Pharmacol; 2009; (193):471-534. PubMed ID: 19639292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does adenosine control neuronal dysfunction and neurodegeneration?
    Cunha RA
    J Neurochem; 2016 Dec; 139(6):1019-1055. PubMed ID: 27365148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role and regulation of adenosine in the central nervous system.
    Dunwiddie TV; Masino SA
    Annu Rev Neurosci; 2001; 24():31-55. PubMed ID: 11283304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adenosine as a modulator of synaptic activity in the central nervous system.
    Brundege JM; Dunwiddie TV
    Adv Pharmacol; 1997; 39():353-91. PubMed ID: 9160120
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.
    Stone TW; Ceruti S; Abbracchio MP
    Handb Exp Pharmacol; 2009; (193):535-87. PubMed ID: 19639293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF; Chern Y
    Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-tuning neuromodulation by adenosine.
    Sebastião AM; Ribeiro JA
    Trends Pharmacol Sci; 2000 Sep; 21(9):341-6. PubMed ID: 10973087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine and adenosine.
    Ribeiro JA; Sebastião AM
    J Alzheimers Dis; 2010; 20 Suppl 1():S3-15. PubMed ID: 20164566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic Signalling and Neurological Diseases: An Update.
    Burnstock G
    CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic signalling: from normal behaviour to pathological brain function.
    Burnstock G; Krügel U; Abbracchio MP; Illes P
    Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders.
    Mattson MP; Liu D
    Neuromolecular Med; 2002; 2(2):215-31. PubMed ID: 12428812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine triphosphate: a multifaceted chemical signal in the nervous system.
    Benarroch EE
    Neurology; 2010 Feb; 74(7):601-7. PubMed ID: 20157163
    [No Abstract]   [Full Text] [Related]  

  • 16. Adenosine and the nervous system: pharmacological data and therapeutic perspectives.
    Guieu R; Dussol B; Halimi G; Bechis G; Sampieri F; Berland Y; Sampol J; Couraud F; Rochat H
    Gen Pharmacol; 1998 Oct; 31(4):553-61. PubMed ID: 9792214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells.
    Franco R; Lillo A; Rivas-Santisteban R; Reyes-Resina I; Navarro G
    Cells; 2021 May; 10(5):. PubMed ID: 34066933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A2 receptor-mediated excitatory actions on the nervous system.
    Sebastião AM; Ribeiro JA
    Prog Neurobiol; 1996 Feb; 48(3):167-89. PubMed ID: 8735876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine Receptors in Modulation of Central Nervous System Disorders.
    Choudhury H; Chellappan DK; Sengupta P; Pandey M; Gorain B
    Curr Pharm Des; 2019; 25(26):2808-2827. PubMed ID: 31309883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine and related drugs in brain diseases: present and future in clinical trials.
    Lopes LV; Sebastião AM; Ribeiro JA
    Curr Top Med Chem; 2011; 11(8):1087-101. PubMed ID: 21401493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.